Testing effectiveness (Phase 2)Ended earlyNCT04088760
What this trial is testing
TCRαβ+/CD19+ Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Malignant and Non-malignant Disorders
Who this might be right for
Allogeneic Hematopoietic Cell Transplantation
Children's Hospital Medical Center, Cincinnati 15